-
December 10, 2021 Psychedelic Business Spotlight – December 10This week in psychedelic business news: Wesana Health files a new patent, Silo Pharma is...
-
December 9, 2021 Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on ‘Well-Tolerated’ DerivativeFurther in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically...
-
December 8, 2021 You Can Make ‘Bad Trips’ Good with Storytelling, Psychedelics Study ShowsEvidence supports the idea that the possibly unpleasant nature of the psychedelic experience is an...
-
December 8, 2021 Toronto Moves to Decriminalize PsychedelicsProposed legislation decriminalizes personal possession and use of all illegal drugs in an effort to...
-
December 7, 2021 Microdosing LSD and Psilocybin Rises During Pandemic, Global Drug Survey FindsThe report also explores how microdosing may impact the use of other prescribed mental health...
-
December 3, 2021 Psychedelic Business Spotlight: December 3This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a...
-
December 2, 2021 DEA Boosts Psychedelics Production (Again) to Meet Research DemandDrug Enforcement Agency also addresses concerns from Native American Church regarding peyote poaching for mescaline...
-
December 2, 2021 Celebrities: Are They Helping or Harming the Psychedelic Movement?Two industry insiders weigh in on the question as more and more of the world's...
-
December 1, 2021 Compass Pathways Releases Promising New Data from Landmark Psilocybin Therapy TrialChief Medical Officer Dr. Guy Goodwin clarifies "COMP360 psilocybin therapy was generally well-tolerated" by patients...
-
November 30, 2021 New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression“If the results are confirmed in subsequent studies ... antidepressants may no longer need to...
